ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
iBio Inc

iBio Inc (IBIO)

2,96
0,02
(0,68%)
Geschlossen 30 Januar 10:00PM
2,96
0,00
( 0,00% )
Vor Marktöffnung: 10:03AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
2,96
Gebot
-
Fragen
-
Volumen
-
0,00 Tagesbereich 0,00
1,05 52-Wochen-Bereich 4,98
Marktkapitalisierung
Handelsende
2,96
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
148.163
Ausgegebene Aktien
9.149.470
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,09
Gewinn pro Aktie (EPS)
-2,72
Erlöse
225k
Nettogewinn
-24,91M

Über iBio Inc

iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing ... iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: biologics development and licensing activities, conducted within iBio, Inc. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
New York, New York, USA
Gegründet
-
iBio Inc is listed in the Pharmaceutical Preparations sector of the Amerikanische Börse with ticker IBIO. The last closing price for iBio was US$2,96. Over the last year, iBio shares have traded in a share price range of US$ 1,05 to US$ 4,98.

iBio currently has 9.149.470 shares in issue. The market capitalisation of iBio is US$27,08 million. iBio has a price to earnings ratio (PE ratio) of -1.09.

IBIO Neueste Nachrichten

iBio Announces New Investments from Board Members and Officers

SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA: IBIO), an AI-driven innovator of precision antibody immunotherapies, announced today the closing of a private placement offering...

iBio Discovers Novel Antibody Targeting Activin E in Collaboration with AstralBio

SAN DIEGO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA: IBIO), an AI-driven innovator of precision antibody immunotherapies, in collaboration with AstralBio Inc., announced today the...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.08-2.631578947373.043.132.72697123.00102879CS
40.4618.42.53.352.31352630692.85682909CS
120.4116.07843137252.553.352.06461481632.70250231CS
260.8338.96713615022.133.351.51279612.55320553CS
521.82159.6491228071.144.981.0510553803.33474928CS
156-6.388-68.33547282849.34873.21.0214136440311.02855776CS
260-1.84-38.33333333334.81571.0214645130738.15962CS

IBIO - Frequently Asked Questions (FAQ)

What is the current iBio share price?
The current share price of iBio is US$ 2,96
How many iBio shares are in issue?
iBio has 9.149.470 shares in issue
What is the market cap of iBio?
The market capitalisation of iBio is USD 27,08M
What is the 1 year trading range for iBio share price?
iBio has traded in the range of US$ 1,05 to US$ 4,98 during the past year
What is the PE ratio of iBio?
The price to earnings ratio of iBio is -1,09
What is the cash to sales ratio of iBio?
The cash to sales ratio of iBio is 120,33
What is the reporting currency for iBio?
iBio reports financial results in USD
What is the latest annual turnover for iBio?
The latest annual turnover of iBio is USD 225k
What is the latest annual profit for iBio?
The latest annual profit of iBio is USD -24,91M
What is the registered address of iBio?
The registered address for iBio is 251 LITTLE FALLS DRIVE, NEW YORK, NEW YORK, 19808
What is the iBio website address?
The website address for iBio is www.ibioinc.com
Which industry sector does iBio operate in?
iBio operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SQYYieldMax SQ Option Income Strategy ETF
US$ 20,08
(11,74%)
164
YCBDcbdMD Inc
US$ 0,613
(11,45%)
17,34k
GNSGenius Group Limited
US$ 0,548
(10,66%)
3,64k
EVBNEvans Bancorp Inc
US$ 46,99
(9,61%)
4
EXODExodus Movement Inc
US$ 97,00
(8,62%)
38
REPXRiley Exploration Permian Inc
US$ 31,21
(-7,83%)
2
ACUAcme United Corp
US$ 34,00
(-7,56%)
101
MSFXT Rex 2X Long Microsoft Daily Target ETF
US$ 26,35
(-7,54%)
1,84k
EVIEVI Industries Inc
US$ 16,00
(-7,25%)
5
PILLDirexion Daily Pharmaceutical & Medical Bull 3x Shares
US$ 7,64
(-6,94%)
30
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 26,60
(3,58%)
268,16k
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2,365
(-5,96%)
256,49k
ETHU2x Ether ETF
US$ 6,73
(4,26%)
155,52k
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 9,84
(2,50%)
118,96k
SOXSDirexion Daily Semiconductor Bear 3X Shares New
US$ 20,95
(-3,81%)
97,26k
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock